Genetic testing company 23andMe can proceed with a $305 million sale to the company’s co-founder Anne Wojcicki after a U.S.

When popular genetic testing company 23andMe filed for bankruptcy earlier this year and announced it was for sale, privacy ...

Dealing with these decisions isn’t easy while undergoing cancer treatment. But yes, it’s completely understandable to ...

The government is working on guidelines for direct-to-consumer genetic testing for underage children, mandating the consent ...

Clinical implementation of genetic testing in children with neurodevelopmental disabilities in the Medicaid-enrolled population remains low.

Rare genetic diseases are challenging for patients and their families—made all the more overwhelming because symptoms tend to ...

Guidance is provided for the pediatrician regarding the genetic evaluation of developmental delay/intellectual disability.

Personalized CRISPR cures for children born with rare genetic diseases are now a step closer to being more widely available.

Learning I carried the BRCA1 mutation was terrifying, but it gave me the power to choose prevention, embrace survivorship, ...

After years of collecting consumer DNA, genetic testing companies are monetizing the data. But who should profit — the ...

Anne Wojcicki's nonprofit TTAM Research Institute will purchase "substantially all" of San Francisco-based 23andMe's assets.

Shoshana Ungerleider is many things: an internal medicine physician, a science journalist, a San Francisco resident, a host ...